CXCL10 and type 1 diabetes mellitus: The inflammatory cytokines CXCL10 [9] and interleukin-1β (IL-1β) [10,11] may lead to damage of the islet cells in the pancreas, and individuals that develop T1D may have a reduced ability to create IL-4 prior to T1D development [12].